XML 22 R13.htm IDEA: XBRL DOCUMENT
v3.24.3

Investments in Other Entities | 9 Months Ended
--- | ---
Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract] |
Investments in Other Entities | 5. Investments in Other Entities Equity Method For the nine months ended September 30, 2024 and 2023, the Company’s equity method investment balance consisted of the following (in thousands):
|  | % of Ownership |  | December 31, 2023 |  |  | Initial Investment |  |  | Allocation of Net Income (Loss) |  |  | September 30, 2024 |
LaSalle Medical Associates – IPA line of business |  | 25% |  | $ | 9,866 |  |  | $ | — |  |  | $ | 2,225 |  |  | $ | 12,091 |
Pacific Medical Imaging & Oncology Center, Inc. |  | 40% |  |  | 1,691 |  |  |  | — |  |  |  | (72 | ) |  |  | 1,619 |
CAIPA MSO, LLC |  | 30% |  |  | 13,660 |  |  |  | — |  |  |  | 643 |  |  |  | 14,303 |
I Health, Inc. |  | 25% |  |  | — |  |  |  | 5,968 |  |  |  | 20 |  |  |  | 5,988 |
Other* |  | 25% |  |  | 557 |  |  |  | — |  |  |  | 71 |  |  |  | 628 |
|  |  |  | $ | 25,774 |  |  | $ | 5,968 |  |  | $ | 2,887 |  |  | $ | 34,629 |
|  | % of Ownership |  | December 31, 2022 |  |  | Initial Investment |  |  | Allocation of Net Income (Loss) |  |  | Funding |  |  | September 30, 2023 |
LaSalle Medical Associates – IPA line of business |  | 25% |  | $ | 5,684 |  |  | $ | — |  |  | $ | 2,642 |  |  | $ | — |  |  | $ | 8,326 |
Pacific Medical Imaging & Oncology Center, Inc. |  | 40% |  |  | 1,878 |  |  |  | — |  |  |  | (219 | ) |  |  | — |  |  |  | 1,659 |
531 W. College, LLC ** |  | 50% |  |  | 17,281 |  |  |  | — |  |  |  | (387 | ) |  |  | 700 |  |  |  | 17,594 |
One MSO, LLC ** |  | 50% |  |  | 2,718 |  |  |  | — |  |  |  | 330 |  |  |  | — |  |  |  | 3,048 |
CAIPA MSO, LLC |  | 30% |  |  | 12,738 |  |  |  | — |  |  |  | 575 |  |  |  | — |  |  |  | 13,313 |
Other* |  | 25% |  |  | — |  |  |  | 325 |  |  |  | 163 |  |  |  | — |  |  |  | 488 |
|  |  |  | $ | 40,299 |  |  | $ | 325 |  |  | $ | 3,104 |  |  | $ | 700 |  |  | $ | 44,428 |
*Other consists of smaller equity method investments. ** Investments were solely for the benefit of APC and its shareholders. For three months ended September 30, 2024 and 2023, the Company’s equity method investment balance consisted of the following (in thousands):
|  | % of Ownership |  | June 30, 2024 |  |  | Initial Investment |  |  | Allocation of Net Income (Loss) |  |  | September 30, 2024 |
LaSalle Medical Associates – IPA line of business |  | 25% |  | $ | 11,027 |  |  | $ | — |  |  | $ | 1,064 |  |  | $ | 12,091 |
Pacific Medical Imaging & Oncology Center, Inc. |  | 40% |  |  | 1,648 |  |  |  | — |  |  |  | (29 | ) |  |  | 1,619 |
CAIPA MSO, LLC |  | 30% |  |  | 14,100 |  |  |  | — |  |  |  | 203 |  |  |  | 14,303 |
I Health, Inc. |  | 25% |  |  | 5,923 |  |  |  | — |  |  |  | 65 |  |  |  | 5,988 |
Other* |  | 25% |  |  | 578 |  |  |  | — |  |  |  | 50 |  |  |  | 628 |
|  |  |  | $ | 33,276 |  |  | $ | — |  |  | $ | 1,353 |  |  | $ | 34,629 |
|  | % of Ownership |  | June 30, 2023 |  |  | Initial Investment |  |  | Allocation of Net Income (Loss) |  |  | Funding |  |  | September 30, 2023 |
LaSalle Medical Associates – IPA line of business |  | 25% |  | $ | 10,537 |  |  | $ | — |  |  | $ | (2,211 | ) |  | $ | — |  |  | $ | 8,326 |
Pacific Medical Imaging & Oncology Center, Inc. |  | 40% |  |  | 1,655 |  |  |  | — |  |  |  | 4 |  |  |  | — |  |  |  | 1,659 |
531 W. College, LLC ** |  | 50% |  |  | 17,070 |  |  |  | — |  |  |  | (176 | ) |  |  | 700 |  |  |  | 17,594 |
One MSO, LLC ** |  | 50% |  |  | 2,960 |  |  |  | — |  |  |  | 88 |  |  |  | — |  |  |  | 3,048 |
CAIPA MSO, LLC |  | 30% |  |  | 13,190 |  |  |  | — |  |  |  | 123 |  |  |  | — |  |  |  | 13,313 |
Other* |  | 25% |  |  | 420 |  |  |  | — |  |  |  | 68 |  |  |  | — |  |  |  | 488 |
|  |  |  | $ | 45,832 |  |  | $ | — |  |  | $ | (2,104 | ) |  | $ | 700 |  |  | $ | 44,428 |
* Other consists of smaller equity method investments. ** Investments were solely for the benefit of APC and its shareholders. I Health, Inc. On March 31, 2024, a wholly owned subsidiary of the Company acquired a 25% equity interest in I Health, Inc. (“I Health”), a management service organization. The Company accounts for its investment in I Health under the equity method of accounting as the Company has the ability to exercise significant influence, but not control over, I Health’s operations. The purchase agreement includes a call option that allows the Company to purchase an additional 25% equity interest on each of the first, second, and third anniversary of the purchase (“I Health Call Option”). The total purchase price for this arrangement was $9.9 million, consisting of $3.9 million in the form of a call option, and $6.0 million as the initial investment of the 25% equity interest. Refer to Note 19 - “Fair Value Measurements of Financial Instruments” for additional information about the I Health Call Option. There w as no i mpairment loss recorded related to equity method investments for the three and nine months ended September 30, 2024 and 2023.

X
- Definition Equity Method And Other Equity Investments [Text Block] + References No definition available. + Details
Name: | asth_EquityMethodAndOtherEquityInvestmentsTextBlock
Namespace Prefix: | asth_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration